Meredith McKean, Andrew Haydon, Sophia Frentzas, Siwen Hu-Lieskovan, Paul L. de Souza, John D. Powderly, Drew W. Rasco, Andrew James Weickhardt, Ganessan Kichenadasse, Vinod Ganju, Nehal J. Lakhani, Catherine Angela Oakman, Jeffrey Thomas Yorio, Ramaswamy Govindan, Jeffrey Ward, Timothy Wyant, Lori Richards, Aron Knickerbocker, Yanay Ofran, James Robert Vasselli. "Imneskibart + low-dose subcutaneous IL-2 ± nivolumab in patients with CPI-refractory cutaneous melanoma: Promising results from an ongoing phase 1/2 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.9526